当前位置: 首页 > 期刊 > 《中国实用医药》 > 2009年第1期
编号:11727743
舒血宁注射液对急性心肌梗死非血运重建患者内皮素、P选择素的影响
http://www.100md.com 2009年1月5日 《中国实用医药》 2009年第1期
舒血宁注射液对急性心肌梗死非血运重建患者内皮素、P选择素的影响

     【摘要】目的 探讨舒血宁注射液对急性心肌梗死非血运重建患者内皮素、P选择素的影响。方法 将70例急性心肌梗死非血运重建患者随机分为治疗组(舒血宁注射液+常规药物治疗)、对照组(常规药物治疗), 观察两组患者治疗14 d后血浆内皮素、P选择素的变化。结果 舒血宁注射液治疗组血浆内皮素、P选择素水平降低,与对照组比较差异有统计学意义(P<0.05)。结论 舒血宁注射液对急性心肌梗死患者有改善血管内皮功能障碍、抗血小板活化的作用。

    【关键词】舒血宁注射液;急性心肌梗死;内皮素;P选择素

    The impact of Shuxuening injection to Endothelin and P-selectin of acute myocardial infarction in patients with non-revascularization

    JIANG Chun-xiao.

    The Eighth People's Hospital of Zibo, Shandong Province 255010, China

    【Abstract】Objective To explore the impact of Shuxuening injection to Endothelin and P-selectin of acute myocardial infarction in patients with non-revascularization. Methods 70 cases of acute myocardial infarction in patients with non-revascularization were randomly divided into treatment group (Shuxuening injection + conventional drug therapy), the control group (conventional drug therapy), patients were observed for the change of plasma Endothelin, P-selectin level after 14 days. Results The plasma Endothelinand P-selectin levels decrease in the treatment group with Shuxuening injection, compared with the control group there were significant differences (P<0.05).Conclusion For the patients with acute myocardial infarction, Shuxuening injection can improve their vascular endothelial dysfunction, and make the role of anti-platelet activation. ......

您现在查看是摘要页,全文长 6464 字符